EFHB
gene geneOn this page
Also known as FLJ25200CFAP21
Summary
EFHB (EF-hand domain family member B, HGNC:26330) is a protein-coding gene on chromosome 3p24.3, encoding EF-hand domain-containing family member B (Q8N7U6). Microtubule inner protein (MIP) part of the dynein-decorated doublet microtubules (DMTs) in cilia axoneme, which is required for motile cilia beating.
Enables calcium ion sensor activity. Involved in regulation of calcineurin-NFAT signaling cascade and regulation of store-operated calcium entry. Located in axonemal microtubule.
Source: NCBI Gene 151651 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 137 total — 2 pathogenic
- MANE Select transcript:
NM_144715
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:26330 |
| Approved symbol | EFHB |
| Name | EF-hand domain family member B |
| Location | 3p24.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ25200, CFAP21 |
| Ensembl gene | ENSG00000163576 |
| Ensembl biotype | protein_coding |
| Entrez | 151651 |
Gene structure
Transcript identifiers
Ensembl transcripts: 7 — 3 protein_coding, 3 protein_coding_CDS_not_defined, 1 non_stop_decay
ENST00000295824, ENST00000344838, ENST00000389256, ENST00000440022, ENST00000467602, ENST00000474780, ENST00000498089
RefSeq mRNA: 2 — MANE Select: NM_144715
NM_001330688, NM_144715
CCDS: CCDS33715, CCDS82744
Canonical transcript exons
ENST00000295824 — 13 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001076161 | 19884403 | 19884615 |
| ENSE00001076163 | 19882550 | 19882731 |
| ENSE00001505285 | 19888444 | 19888651 |
| ENSE00001558804 | 19879472 | 19879804 |
| ENSE00001900720 | 19933230 | 19934217 |
| ENSE00003468226 | 19920505 | 19920567 |
| ENSE00003482325 | 19915303 | 19915413 |
| ENSE00003486692 | 19918232 | 19918412 |
| ENSE00003544891 | 19905620 | 19905749 |
| ENSE00003546035 | 19919833 | 19919976 |
| ENSE00003619329 | 19896687 | 19896841 |
| ENSE00003651084 | 19898778 | 19898845 |
| ENSE00003679591 | 19899432 | 19899515 |
Expression profiles
Bgee: expression breadth ubiquitous, 171 present calls, max score 97.49.
FANTOM5 (CAGE): breadth broad, TPM avg 1.0239 / max 41.6695, expressed in 494 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 41412 | 0.7594 | 406 |
| 41411 | 0.2645 | 103 |
Top tissues by expression
245 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| bronchial epithelial cell | CL:0002328 | 97.49 | gold quality |
| bronchus | UBERON:0002185 | 95.72 | gold quality |
| right uterine tube | UBERON:0001302 | 90.30 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 89.07 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 88.76 | gold quality |
| oviduct epithelium | UBERON:0004804 | 86.56 | gold quality |
| sperm | CL:0000019 | 85.00 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 84.52 | gold quality |
| left testis | UBERON:0004533 | 83.53 | gold quality |
| right testis | UBERON:0004534 | 82.79 | gold quality |
| testis | UBERON:0000473 | 81.77 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 81.20 | gold quality |
| fallopian tube | UBERON:0003889 | 80.68 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 76.21 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 74.93 | silver quality |
| stromal cell of endometrium | CL:0002255 | 73.32 | gold quality |
| caput epididymis | UBERON:0004358 | 73.11 | gold quality |
| sural nerve | UBERON:0015488 | 72.28 | gold quality |
| metanephros cortex | UBERON:0010533 | 71.95 | gold quality |
| nasal cavity mucosa | UBERON:0001826 | 71.76 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 70.63 | gold quality |
| cortical plate | UBERON:0005343 | 69.77 | gold quality |
| right lung | UBERON:0002167 | 69.40 | gold quality |
| hypothalamus | UBERON:0001898 | 68.83 | gold quality |
| spinal cord | UBERON:0002240 | 68.04 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 67.99 | gold quality |
| amygdala | UBERON:0001876 | 67.92 | gold quality |
| right adrenal gland | UBERON:0001233 | 67.14 | gold quality |
| ventricular zone | UBERON:0003053 | 66.96 | gold quality |
| tibial nerve | UBERON:0001323 | 66.84 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 7.15 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
10 targeting EFHB, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4668-3P | 100.00 | 68.74 | 2635 |
| HSA-MIR-4803 | 99.98 | 71.99 | 3117 |
| HSA-MIR-6885-3P | 99.75 | 70.36 | 3187 |
| HSA-MIR-4735-5P | 99.43 | 68.49 | 1780 |
| HSA-MIR-889-3P | 99.40 | 69.76 | 2103 |
| HSA-MIR-7151-3P | 99.04 | 69.72 | 2370 |
| HSA-MIR-4272 | 98.76 | 68.74 | 1810 |
| HSA-MIR-4766-3P | 98.48 | 67.94 | 1347 |
| HSA-MIR-618 | 97.62 | 67.46 | 861 |
| HSA-MIR-4680-5P | 96.43 | 67.15 | 893 |
Literature-anchored findings (GeneRIF, showing 2)
- EFHB is a Novel Cytosolic Ca2+ Sensor That Modulates STIM1-SARAF Interaction (PMID:30481768)
- EFHB is a new store-operated Ca2+ entry regulator that modulates STIM1-SARAF interaction. (PMID:30481768)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | efhb | ENSDARG00000069703 |
| mus_musculus | Efhb | ENSMUSG00000023931 |
| rattus_norvegicus | Efhb | ENSRNOG00000012618 |
| caenorhabditis_elegans | WBGENE00013028 |
Paralogs (2): EFHC1 (ENSG00000096093), EFHC2 (ENSG00000183690)
Protein
Protein identifiers
EF-hand domain-containing family member B — Q8N7U6 (reviewed: Q8N7U6)
Alternative names: Cilia- and flagella-associated protein 21
All UniProt accessions (3): Q8N7U6, H7C0U4, H9KV82
UniProt curated annotations — full annotation on UniProt →
Function. Microtubule inner protein (MIP) part of the dynein-decorated doublet microtubules (DMTs) in cilia axoneme, which is required for motile cilia beating. Cytosolic sensor for calcium, modulates the interaction of STIM1 and ORAI1 upon store depletion and the activation of store-operated Ca(2+) entry (SOCE) and NFAT translocation from cytosol to nucleus.
Subunit / interactions. Microtubule inner protein component of sperm flagellar doublet microtubules. Interacts with STIM1 and ORAI1; the interactions take place upon Ca(2+)-store depletion and dissociate through a Ca(2+)-dependent mechanism. Interaction with STIM1 inhibits STIM1 interaction with SARAF.
Subcellular location. Cytoplasm. Cytoskeleton. Cilium axoneme. Flagellum axoneme.
Tissue specificity. Expressed in airway epithelial cells.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8N7U6-1 | 1 | yes |
| Q8N7U6-2 | 2 | |
| Q8N7U6-3 | 3 |
RefSeq proteins (2): NP_001317617, NP_653316* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR002048 | EF_hand_dom | Domain |
| IPR011992 | EF-hand-dom_pair | Homologous_superfamily |
| IPR018247 | EF_Hand_1_Ca_BS | Binding_site |
| IPR040193 | EFHC1/EFHC2/EFHB | Family |
| IPR057428 | EFHB_EF-hand_C | Domain |
Pfam: PF13499, PF25325
UniProt features (27 total): binding site 8, sequence variant 6, sequence conflict 6, splice variant 4, domain 2, chain 1
Structure
Experimental structures (PDB)
2 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 7UNG | ELECTRON MICROSCOPY | 3.6 |
| 8J07 | ELECTRON MICROSCOPY | 4.1 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8N7U6-F1 | 63.23 | 0.05 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Ligand- & substrate-binding residues (8): 621; 574; 578; 580; 585; 610; 612; 614
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 104 (showing top):
GOBP_REGULATION_OF_PROTEIN_BINDING, GOBP_REGULATION_OF_CALCIUM_MEDIATED_SIGNALING, GOBP_MONOATOMIC_CATION_TRANSPORT, GOBP_NEGATIVE_REGULATION_OF_PROTEIN_BINDING, SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN, GOBP_CILIUM_MOVEMENT, GOBP_CILIUM_OR_FLAGELLUM_DEPENDENT_CELL_MOTILITY, GOBP_NEGATIVE_REGULATION_OF_MOLECULAR_FUNCTION, RYTTCCTG_ETS2_B, GOBP_REGULATION_OF_TRANSPORT, GOBP_REGULATION_OF_MONOATOMIC_ION_TRANSPORT, NERF_Q2, GOCC_CYTOPLASMIC_REGION, GOCC_MOTILE_CILIUM, GOCC_CYTOPLASMIC_MICROTUBULE
GO Biological Process (6): calcium ion transport (GO:0006816), flagellated sperm motility (GO:0030317), negative regulation of protein binding (GO:0032091), regulation of calcineurin-NFAT signaling cascade (GO:0070884), regulation of store-operated calcium entry (GO:2001256), monoatomic ion transport (GO:0006811)
GO Molecular Function (4): calcium ion binding (GO:0005509), calcium ion sensor activity (GO:0061891), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (8): axonemal microtubule (GO:0005879), sperm flagellum (GO:0036126), axonemal A tubule inner sheath (GO:0160111), cytoplasm (GO:0005737), cytoskeleton (GO:0005856), cilium (GO:0005929), motile cilium (GO:0031514), cell projection (GO:0042995)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 3 |
| metal ion transport | 1 |
| cilium-dependent cell motility | 1 |
| cilium movement involved in cell motility | 1 |
| sperm motility | 1 |
| protein binding | 1 |
| regulation of protein binding | 1 |
| negative regulation of binding | 1 |
| calcineurin-NFAT signaling cascade | 1 |
| regulation of calcineurin-mediated signaling | 1 |
| store-operated calcium entry | 1 |
| regulation of calcium ion transport | 1 |
| transport | 1 |
| metal ion binding | 1 |
| calcium ion binding | 1 |
| metal ion sensor activity | 1 |
| binding | 1 |
| cation binding | 1 |
| cytoplasmic microtubule | 1 |
| axoneme | 1 |
| 9+2 motile cilium | 1 |
| A axonemal microtubule | 1 |
| axonemal microtubule doublet inner sheath | 1 |
| intracellular anatomical structure | 1 |
| intracellular membraneless organelle | 1 |
| intraciliary transport particle | 1 |
| membrane-bounded organelle | 1 |
| plasma membrane bounded cell projection | 1 |
| cilium | 1 |
Protein interactions and networks
STRING
2066 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| EFHB | SARAF | Q96BY9 | 718 |
| EFHB | CRACR2A | Q9BSW2 | 619 |
| EFHB | STYXL2 | Q5VZP5 | 516 |
| EFHB | CAPSL | Q8WWF8 | 507 |
| EFHB | SCLY | Q96I15 | 476 |
| EFHB | C9orf43 | Q8TAL5 | 446 |
| EFHB | RAVER1 | Q8IY67 | 442 |
| EFHB | LRFN4 | Q6PJG9 | 441 |
| EFHB | ESPNL | Q6ZVH7 | 435 |
| EFHB | IRAG1 | Q9Y6F6 | 434 |
| EFHB | ORAI1 | Q96D31 | 423 |
| EFHB | STIM1 | Q13586 | 422 |
| EFHB | RCE1 | Q9Y256 | 419 |
| EFHB | GLRB | P48167 | 417 |
| EFHB | GUCY1A2 | P33402 | 411 |
IntAct
7 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| STIM1 | EFHB | psi-mi:“MI:0915”(physical association) | 0.500 |
| STIM1 | EFHB | psi-mi:“MI:0914”(association) | 0.500 |
| ORAI1 | EFHB | psi-mi:“MI:0915”(physical association) | 0.400 |
| M | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (3): EFHB (Affinity Capture-MS), EFHB (Affinity Capture-MS), EFHB (Cross-Linking-MS (XL-MS))
ESM2 similar proteins: A0A1B0GTD5, A0A1B0GUX0, A0A3Q1MT14, A4D263, A6NL82, A6QQL5, A8QW39, B0UXH9, B5X5D0, B9EJX3, E1B9R1, F1MMV1, Q148A4, Q1JPL0, Q2T9T0, Q32KQ1, Q32L72, Q32L77, Q32P67, Q3V0J4, Q5BN46, Q5NC57, Q5NC83, Q5SPV6, Q5SS90, Q5SVJ3, Q5VTT2, Q5VZQ5, Q66HC0, Q66HR9, Q6AYM0, Q6NXP0, Q6P3G4, Q6ZVS7, Q80X60, Q8CDT5, Q8CDU5, Q8N5S3, Q8N7U6, Q8N865
Diamond homologs: A5PJZ1, F1MMV1, O18757, P02597, P28583, P48593, Q0DYK7, Q2QVG8, Q40302, Q6AVI8, Q6NUK1, Q8BMD8, Q8CDU5, Q8N7U6, Q9FXQ3, Q9M9V8, Q9SSF8, Q9SZM3, A0A5K1K8H0, A8CEP3, O49717, O60041, P02612, P04464, P05419, P05933, P06704, P06787, P0DP23, P0DP24, P0DP26, P0DP27, P0DP29, P0DP33, P11121, P13832, P14533, P18061, P24032, P24844
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
137 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 2 |
| Likely pathogenic | 0 |
| Uncertain significance | 118 |
| Likely benign | 8 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (2)
| Variant ID | HGVS | Classification |
|---|---|---|
| 57979 | GRCh38/hg38 3p24.3-24.2(chr3:19915382-25537973)x3 | Pathogenic |
| 687662 | GRCh37/hg19 3p24.3-24.1(chr3:19064852-26448689)x1 | Pathogenic |
SpliceAI
2373 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 3:19884401:A:AC | donor_gain | 1.0000 |
| 3:19884402:C:CC | donor_gain | 1.0000 |
| 3:19884423:A:AC | donor_gain | 1.0000 |
| 3:19884424:C:CC | donor_gain | 1.0000 |
| 3:19884515:T:TA | donor_gain | 1.0000 |
| 3:19896681:A:AC | donor_gain | 1.0000 |
| 3:19896682:C:CC | donor_gain | 1.0000 |
| 3:19896739:A:C | donor_gain | 1.0000 |
| 3:19896743:T:A | donor_gain | 1.0000 |
| 3:19896837:AACTC:A | acceptor_gain | 1.0000 |
| 3:19896839:CTC:C | acceptor_gain | 1.0000 |
| 3:19896840:TC:T | acceptor_gain | 1.0000 |
| 3:19896841:CC:C | acceptor_gain | 1.0000 |
| 3:19896841:CCTA:C | acceptor_loss | 1.0000 |
| 3:19896842:C:CC | acceptor_gain | 1.0000 |
| 3:19896845:T:TC | acceptor_gain | 1.0000 |
| 3:19898029:C:CA | donor_gain | 1.0000 |
| 3:19898841:CAATG:C | acceptor_gain | 1.0000 |
| 3:19898844:TG:T | acceptor_gain | 1.0000 |
| 3:19898846:C:CC | acceptor_gain | 1.0000 |
| 3:19899430:A:AC | donor_gain | 1.0000 |
| 3:19899431:C:CC | donor_gain | 1.0000 |
| 3:19899431:CGGAT:C | donor_gain | 1.0000 |
| 3:19905613:AACTT:A | donor_loss | 1.0000 |
| 3:19905614:ACTT:A | donor_loss | 1.0000 |
| 3:19905615:CTTAC:C | donor_loss | 1.0000 |
| 3:19905616:TTACA:T | donor_loss | 1.0000 |
| 3:19905617:T:TC | donor_loss | 1.0000 |
| 3:19905618:A:AC | donor_gain | 1.0000 |
| 3:19905618:A:T | donor_loss | 1.0000 |
AlphaMissense
5474 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 3:19888511:G:C | F622L | 0.994 |
| 3:19888511:G:T | F622L | 0.994 |
| 3:19888513:A:G | F622L | 0.994 |
| 3:19896723:A:C | F563L | 0.990 |
| 3:19896723:A:T | F563L | 0.990 |
| 3:19896725:A:G | F563L | 0.990 |
| 3:19888512:A:G | F622S | 0.987 |
| 3:19888620:A:G | L586P | 0.985 |
| 3:19888502:A:C | F625L | 0.983 |
| 3:19888502:A:T | F625L | 0.983 |
| 3:19888504:A:G | F625L | 0.983 |
| 3:19896702:G:C | F570L | 0.983 |
| 3:19896702:G:T | F570L | 0.983 |
| 3:19896704:A:G | F570L | 0.983 |
| 3:19888635:A:T | I581K | 0.981 |
| 3:19888552:A:G | C609R | 0.980 |
| 3:19896748:A:G | L555P | 0.978 |
| 3:19888510:C:G | A623P | 0.977 |
| 3:19896757:C:G | R552P | 0.976 |
| 3:19905692:C:T | G449E | 0.975 |
| 3:19888500:A:G | L626P | 0.974 |
| 3:19888527:A:T | I617N | 0.974 |
| 3:19896744:C:A | K556N | 0.974 |
| 3:19896744:C:G | K556N | 0.974 |
| 3:19896703:A:G | F570S | 0.973 |
| 3:19888550:A:C | C609W | 0.971 |
| 3:19888563:A:G | L605P | 0.971 |
| 3:19888527:A:C | I617S | 0.970 |
| 3:19888551:C:T | C609Y | 0.969 |
| 3:19919905:A:C | F308L | 0.969 |
dbSNP variants (sampled 300 via entrez): RS1000046787 (3:19896370 C>T), RS1000126061 (3:19883513 A>G), RS1000162183 (3:19931491 G>A,C), RS1000179100 (3:19925190 C>T), RS1000236300 (3:19931257 A>T), RS1000330954 (3:19919224 T>C), RS1000332591 (3:19882994 TTTTTTC>T,TTTTTTCTTTTTC), RS1000357944 (3:19947822 G>C,T), RS1000397094 (3:19913903 G>A), RS1000408981 (3:19883773 G>C), RS1000538648 (3:19909028 A>C), RS1000702770 (3:19906283 C>G,T), RS1000794672 (3:19913527 G>A), RS1000842758 (3:19925426 C>A,G), RS1000849822 (3:19941417 G>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
25 total (human), top 25 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects cotreatment, increases expression, decreases expression | 3 |
| entinostat | decreases expression, affects cotreatment | 2 |
| p-Chloromercuribenzoic Acid | affects cotreatment, increases expression | 2 |
| aristolochic acid I | decreases expression | 1 |
| methylmercuric chloride | decreases expression | 1 |
| bisphenol A | affects cotreatment, decreases methylation | 1 |
| trichostatin A | decreases expression | 1 |
| cupric oxide | decreases expression | 1 |
| S-(1,2-dichlorovinyl)cysteine | affects response to substance, increases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, decreases expression, increases expression | 1 |
| dorsomorphin | affects cotreatment, decreases expression, increases expression | 1 |
| Temozolomide | decreases expression | 1 |
| Fulvestrant | affects cotreatment, decreases methylation, increases methylation | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Atrazine | increases expression | 1 |
| Diethylhexyl Phthalate | decreases expression | 1 |
| Hydralazine | affects cotreatment, increases expression | 1 |
| Lipopolysaccharides | affects response to substance, increases expression | 1 |
| Nickel | decreases expression | 1 |
| Oxygen | increases expression | 1 |
| Smoke | increases abundance, increases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Cadmium Chloride | decreases expression | 1 |
| Copper Sulfate | decreases expression | 1 |
| Acrylamide | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.